Inhibition of endothelial cell function in Vitro and angiogenesis in Vivo by docetaxel (taxotere): Association with impaired repositioning of the microtubule organizing center

Molecular Cancer Therapeutics

Volumn 1, Issue 13, 2002, Pages 1191-1200

  Hotchkiss, Kylie A ^a   Ashton, Anthony W ^a   Mahmood, Radma ^a   Russell, Robert G ^a   Sparano, Joseph A ^a   Schwartz, Edward L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGEN; DOCETAXEL; DRUG DERIVATIVE; FIBROBLAST GROWTH FACTOR 2; LAMININ; MATRIGEL; PACLITAXEL; PROTEOGLYCAN; TAXOID;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL MOTION; CENTROSOME; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL NEOPLASM; HUMAN; IN VITRO STUDY; METABOLISM; MICROTUBULE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RAT; TRANSPLANTATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL MOVEMENT; CELLS, CULTURED; CENTROSOME; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; LAMININ; MICE; MICE, INBRED C57BL; MICROTUBULES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; PROTEOGLYCANS; RATS; TAXOIDS; TUMOR CELLS, CULTURED; UMBILICAL VEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0038105608     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Rowinsky, E. K. and Donehower, R. C. Antimicrotubule Agents. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 467-483. Philadelphia: Lippincott- Raven Publishers, 1997.
2. Nabholtz, J. M., Senn, H. J., Bezwoda, W. R., Melnychuk, D., Deschenes, L., Douma, J., Vandenberg, T. A., Rapoport, B., Rosso, R., Trillet-Lenoir, V., Drbal, J., Molino, A., Nortier, J. W., Richel, D. J., Nagykalnai, T., Siedlecki, P., Wilking, N., Genot, J. Y., Hupperets, P. S., Pannuti, F., Skarlos, D., Tomiak, E. M., Murawsky, M., Alakl, M., Aapro, M., et al. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. J. Clin. Oncol., 17: 1413-1424, 1999. (Pubitemid 29220847)
3. Savarese, D., Halabi, S., Hars, V., Akerley, W. L., Taplin, M. E., Godley, P. A., Hussain, A., Small, E. J., and Vogelzang, N. J. Phase II study of docetaxel, estramustine, and low dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780. J. Clin. Oncol., 19: 2509-2516, 2001. (Pubitemid 32391222)
4. Beer, T., Pierce, W., Lowe, B., and Henner, W. Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Ann. Oncol., 12: 1273-1279, 2001. (Pubitemid 32994757)
5. Shepherd, F. A., Dancey, J., Ramlau, R., Mattson, K., Gralla, R., O'Rourke, M., Levitan, N., Gressot, L., Vincent, M., Burkes, R., Coughlin, S., Kim, Y., and Berille, J. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J. Clin. Oncol., 18: 2095-2103, 2000. (Pubitemid 30324363)
6. Fossella, F. V., DeVore, R., Kerr, R. N., Crawford, J., Natale, R. R., Dunphy, F., Kalman, L., Miller, V., Lee, J. S., Moore, M., Gandara, D., Karp, D., Vokes, E., Kris, M., Kim, Y., Gamza, F., and Hammershaimb, L. Randomized Phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. J. Clin. Oncol., 18: 2354- 2362, 2000.
7. Diaz, J. F., and Andreu, J. M. Assembly of purified GDP-tubulin into microtubules induced by Taxol and Taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry, 32: 2747-2755, 1993. (Pubitemid 23102795)
8. Ringel, I., and Horwitz, S. B. Studies with RP 56976 (Taxotere): a semisynthetic analogue of Taxol. J. Natl. Cancer Inst. (Bethesda), 83: 288-291, 1991.
9. Kelland, L. R., and Abel, G. Comparative in vitro cytotoxicity of Taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol., 30: 444-450, 1992.
10. Lavelle, F., Bissery, M. C., Combeau, C., Riou, J. F., Vrignaud, P., and Andre, S. Preclinical evaluation of docetaxel (Taxotere). Semin. Oncol., 22: 3-16, 1995.
11. Federici, C., Camoin, L., Hattab, M., Strosberg, A. D., and Couraud, P. O. Association of the cytoplasmic domain of intercellular-adhesion molecule-1 with glyceraldehyde-3-phosphate dehydrogenase and β-tubulin. Eur. J. Biochem., 238: 173-180, 1996. (Pubitemid 26164193)
12. Cronstein, B. N., Molad, Y., Reibman, J., Balakhane, E., Levin, R. I., and Weissmann, G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J. Clin. Investig., 96: 994-1002, 1995.
13. Asahina, A., Tada, Y., Nakamura, K., and Tamaki, K. Colchicine and griseofulvin inhibit VCAM-1 expression on human vascular endothelial cells: evidence for the association of VCAM-1 expression with microtubules. J. Dermatol. Sci., 25: 1-9, 2001. (Pubitemid 32012640)
14. Hamm-Alvarez, S. F., Alayof, B. E., Himmel, H. M., Kim, P. Y., Crews, A. L., Strauss, H. C., and Sheetz, M. P. Coordinate depression of bradykinin receptor recycling and microtubule-dependent transport by Taxol. Proc. Natl. Acad. Sci. USA, 91: 7812-7816, 1994.
15. Liu, S. M., Magnusson, K. E., and Sundqvist, T. Microtubules are involved in transport of macromolecules by vesicles in cultured bovine aortic endothelial cells. J. Cell. Physiol., 156: 311-316, 1993. (Pubitemid 23244094)
16. Ding, A. H., Porteu, F., Sanchez, E., and Nathan, C. F. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J. Exp. Med., 171: 715-727, 1990. (Pubitemid 20088977)
17. Vinogradova, T. M., Roudnik, V. E., Bystrevskaya, V. B., and Smirnov, V. N. Centrosome-directed translocation of Weibel-Palade bodies is rapidly induced by thrombin, calyculin A, or cytochalasin B in human aortic endothelial cells. Cell Motil. Cytoskeleton, 47: 141-153, 2000.
18. Vischer, U. M., Barth, H., and Wollheim, C. B. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. Arterioscler. Thromb. Vasc. Biol., 20: 883-891, 2000. (Pubitemid 30151707)
19. Sawyer, S. J., Norvell, S. M., Ponik, S. M., and Pavalko, F. M. Regulation of PGE2 and PGI2 release from human umbilical vein endothelial cells by actin cytoskeleton. Am. J. Physiol. Cell Physiol., 281: C1038-1045, 2001.
20. Watts, M. E., Woodcock, M., Arnold, S., and Chaplin, D. J. Effects of novel and conventional anti-cancer agents on human endothelial permeability: influence of tumour secreted factors. Anticancer Res., 17: 71-75, 1997. (Pubitemid 27116647)
21. Selden, S. C., III, Rabinovitch, P. S., and Schwartz, S. M. Effects of cytoskeletal disrupting agents on replication of bovine endothelium. J. Cell. Physiol., 108: 195-211, 1981. (Pubitemid 11022646)
22. Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., and Taraboletti, G. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin. Cancer Res., 2: 1843-1849, 1996. (Pubitemid 26384151)
23. Klauber, N., Parangi, S., Flynn, E., Hamel, E., and D'Amato. R. J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and Taxol. Cancer Res., 57: 81-86, 1997.
24. Ueda, M., Gräf, R., MacWilliams, H. K., Schliwa, M., and Euteneuer, U. Centrosome positioning and directionality of cell movements. Proc. Natl. Acad. Sci. USA, 94: 9674-9678, 1997.
25. Liao, G., Nagasaki, T., and Gundersen, G. G. Low concentrations of nocodazole interfere with fibroblast locomotion without significantly affecting microtubule level: implications for the role of dynamic microtubules in cell locomotion. J. Cell Sci., 108: 3473-3483, 1995.
26. Sweeney, C. J., Miller, K. D., Sissons, S. E., Nozaki, S., Heilman, D. K., Shen, J., and Sledge, G. W., Jr. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. Cancer Res., 61: 3369-3372, 2001. (Pubitemid 32695027)
27. Ettenson, D. S., and Gotlieb, A. I. Centrosomes, microtubules, and microfilaments in the reendothelialization and remodeling of double-sided in vitro wounds. Lab. Investig., 66: 722-733, 1992.
28. Vyalov, S., Langille, B. L., and Gotlieb, A. I. Decreased blood flow rate disrupts endothelial repair in vivo. Am. J. Pathol., 149: 2107-2118, 1996. (Pubitemid 26415227)
29. Gotlieb, A. I., May, L. M., Subrahmanyan, L., and Kalnins, V. I. Distribution of microtubule organizing centers in migrating sheets of endothelial cells. J. Cell Biol., 91: 589-594, 1981. (Pubitemid 12215650)
30. Coan, D. E., Wechezak, A. R., Viggers, R. F., and Sauvage, L. R. Effect of shear stress upon localization of the Golgi apparatus and microtubule organizing center in isolated cultured endothelial cells. J. Cell Sci., 104:1145-1153, 1993. (Pubitemid 23154322)
31. Coomber, B. L., and Gotlieb, A. I. In vitro endothelial wound repair: interaction of cell migration and proliferation. Arteriosclerosis, 10: 215- 222, 1990.
32. Verweij, J., Clavel, M., and Chevalier, B. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind. Ann. Oncol., 5: 495-505, 1994.
33. Ashton, A. W., Yokota, R., John, G., Zhao, S., Suadicani, S. O., Spray, D. C., and Ware, J. A. Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A2. J. Biol. Chem., 274: 35562-35570, 1999. (Pubitemid 129512852)
34. Terranova, V. P., DiFlorio, R., Lyall, R. M., Hic, S., Friesel, R., and Maciag, T. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J. Cell Biol., 101: 2330-2334, 1985. (Pubitemid 16169965)
35. Tanaka, E., Ase, K., Okuda, T., Okumura, M., and Nogimori, K. Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol. Pharm. Bull., 19: 1141-1148, 1996. (Pubitemid 26342254)
36. Ornitz, D. M., and Itoh, N. Fibroblast growth factors. Genome Biol., 2: 3005, 2001.
37. Miller, K. D., Sweeney, C. J., and Sledge, G. W., Jr. Redefining the target: chemotherapeutics as antiangiogenics. J. Clin. Oncol., 19: 1195-1206, 2001. (Pubitemid 32176298)
38. Browder, T., Butterfield, C. E., Kraling, B. M., Shi, B., Marshall, B., O'Reilly, M. S., and Folkman, J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res., 60: 1878-1886, 2000. (Pubitemid 30207647)
39. Untch, M., Untch, A., Sevin, B. U., Angioli, R., Perras, J. P., Koechli, O., and Averette, H. E. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay. Anticancer Drugs, 5: 24-30, 1994. (Pubitemid 24066558)
40. Neujahr, R., Albrecht, R., Kohler, J., Matzner, M., Schwartz, J. M., Westphal, M., and Gerisch, G. Microtubule-mediated centrosome motility and the positioning of cleavage furrows in multinucleate myosin II-null cells. J. Cell Sci., 111: 1227-1240, 1998. (Pubitemid 28266478)
41. Bissery, M. C., Guenard, D., Gueritte-Voegelein, F., and Lavelle, F. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue. Cancer Res., 51: 4845-4852, 1991.
42. Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., and Kerbel, R. S. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J. Clin. Investig., 105: R15-R24, 2000. (Pubitemid 30217701)
43. Hanahan, D., Bergers, G., and Bergsland, E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J. Clin. Investig., 105: 1045-1047, 2000. (Pubitemid 30217688)
44. Patan, S., Tanda, S., Roberge, S., Jones, R. C., Jain, R. K., and Munn, L. L. Vascular morphogenesis and remodeling in a human tumor xenograft. Blood vessel formation and growth after ovariectomy and tumor implantation. Circ. Res., 89: 732-739, 2001. (Pubitemid 34627074)